Post

New research · Ophthalmology
Ophthalmology and therapy · 2d
Randomized trialOphthalmology and therapy · 2026

Comparative Clinical Outcomes of a 1.0% Versus 1.4% Sodium Hyaluronate OVD in Cataract Surgery: A Prospective Study.

Shreyas Ramamurthy, Dandapani Ramamurthy, Bhavnita Soni, Bhargav Joshi
Read paper
OphthalmologyRandomized trial

Both hyaluronate gel devices kept the eye chamber fully open in every surgery.

Comparative Clinical Outcomes of a 1.0% Versus 1.4% Sodium Hyaluronate OVD in Cataract Surgery: A Prospective Study.

Shreyas Ramamurthy … Bhargav Joshi
Ophthalmology and therapy · 2026
Background

Maintaining anterior chamber space and protecting the endothelial layer during surgery is the primary role of ophthalmic viscosurgical devices (ophthalmic viscosurgical devices), which have made them an integral part of the surgery for decades now.

Purpose

This study evaluated sodium hyaluronate-based OVDs BIO-HYALUR (1%) and Protectalon 1.4% in terms of their performance and safety during cataract surgery.

Methods

This was a prospective, comparative, randomized clinical study involving patients undergoing cataract surgery.

n = 140 patients
Results
100%
the eye's chamber stayed fully open with no collapse in any surgery
n = 140 patients
More results

The study included 140 patients (70 in each group) with a mean age of 63.8 ± 7.09 years and 63.4 ± 8.81 years for the BIO-HYALUR group and the Protectalon group, respectively.

No patient in either of the groups showed an incident of IOP > 30 mmHg during the study period.

More results

Intraocular inflammation was completely resolved by 7 ± 2 days, and lens and corneal clarity was achieved by 24 ± 4 h in both groups.

No statistically significant difference was observed between the two groups for visual acuity and corneal thickness.

“
Conclusion

BIO-HYALUR and Protectalon 1.4% are safe and reliable OVDs in terms of intra- and postoperative parameters, and both OVDs are suitable for cataract surgery.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment